HPV Testing Methods

Human papillomavirus (HPV) is a prevalent sexually transmitted infection that can lead to various types of cancer, including cervical, anal, and oropharyngeal cancer. Early detection and accurate diagnosis of HPV infection are significant in facilitating early detection, risk assessment, and personalized management of HPV infections and related diseases. By identifying high-risk HPV types, guiding screening strategies, monitoring treatment outcomes, and informing vaccination programs, HPV testing plays a vital role in reducing the burden of HPV-related conditions and improving patient outcomes.

Browse all our HPV products

Molecular-Based Methods for HPV Detection

Accurate identification of HPV primarily relies on molecular biology techniques. These techniques utilize nucleic probe technology to detect HPV in clinical specimens. The main clinical applications of HPV DNA testing include:

• Triaging women with equivocal or low-grade cytological abnormalities
• Monitoring women with abnormal screening results but negative colposcopy/biopsy
• Predicting therapeutic outcomes after cervical intraepithelial neoplasia (CIN) treatment
• Primary screening for cervical cancer precursors either alone or in combination with a Pap smear
• Assessing the persistence of specific HPV types
• Investigating the regional and country-based prevalence of type-specific HPV for evaluating the impact of HPV vaccination.

While morphological, serological, and clinical findings can suggest the presence of HPV, accurate diagnosis relies on molecular biology techniques for detection and typing. Nucleic acid-hybridization assays, signal-amplification assays, and nucleic-acid amplification methods are currently available for HPV diagnosis.

Figure 1. Relative sensitivities of nucleic acid analysis techniques.
(Source: Hubbard, R. A. et al., 2003)

Nucleic Acids Hybridization Assays

Traditionally, techniques such as in situ hybridization, Southern blotting, and dot-blot hybridization used radio-labeled nucleic acid hybridization assays to detect HPV infection in cervical samples.

Signal Amplification Assays

These methods improve sensitivity by multimeric layering of reporter molecules on DNA probes. An example of signal amplification is hybrid capture 2 (HC2) detection, in which specific RNA probes are used to target individual DNA sequences containing the HPV genotype to be detected. However, this test cannot determine the specific HPV type present.

Nucleic Acid Amplification Assays

Nucleic acid amplification methods include microarray analysis, PCR, PCR-RFLP, Real-time PCR, HPV genome sequencing, microplate colorimetric hybridization assay (MCHA), HPV-mRNA detection, and others. These methods are technologies that hold great promise for addressing all aspects of HPV testing, including HPV detection, viral load quantitation, DNA sequencing, and mutation analysis.

Methods for Determining HPV Viral Load

It has been reported that HPV-infected patients with high viral loads (VL) may be at an increased risk of developing cervical cancer. RQ-PCR-based assays represent the best method for quantification of target nucleic acids and allow continuous monitoring of PCR products. Quantification of HPV DNA using real-time PCR has the advantage of being rapid, reproducible, and suitable for the clinical setting. Moreover, other techniques such as HC2 assays can also be used for semi-quantification of HPV VL in clinical samples.

HPV Antibodies

HPV Antigens

HPV ELISA Kits